Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2012 by Massachusetts Eye and Ear Infirmary.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Massachusetts Eye and Ear Infirmary Identifier:
First received: November 19, 2010
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)